Herbal dietary supplement supporting healthy immune function

Abstract

An herbal formulation including effective amounts of cat's claw extract, Astragalus extract, Echinacea extract, Moringa extract; astaxanthin, black elderberry extract, vitamin B12, blackseed extract, oregano extract; garlic extract; tumeric extract, and vitamin E provides nutritional support for healthy immune function. The herbal formulation may be packaged in dosage forms that are particularly effective in fighting infections, and especially viral infections.

Claims

1. A capsule, pill, or gummy treat herbal formulation consisting essentially of: cat's claw extract; Astragalus extract; Echinacea extract; Moringa extract; astaxanthin; black elderberry extract; vitamin B12; blackseed extract; oregano extract; garlic extract; tumeric extract; and vitamin E.

2. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of cat's claw extract ranges from 5.3 weight percent to 6.5 weight percent of said herbal formulation.

3. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of Astragalus extract ranges from 5.3 weight percent to 6.5 weight percent of said herbal formulation.

4. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of Echinacea extract ranges from 5.1 weight percent to 6.3 weight percent of said herbal formulation.

5. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of Moringa extract ranges from 16.7 weight percent to 20.4 weight percent of said herbal formulation.

6. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of astaxanthin ranges from 0.35 weight percent to 0.42 weight percent of said herbal formulation.

7. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of black elderberry extract ranges from 4.9 weight percent to 5.9 weight percent of said herbal formulation.

8. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of vitamin B12 ranges from 9.0 weight percent to 11.0 weight percent of said herbal formulation.

9. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of blackseed extract ranges from 3.5 weight percent to 4.2 weight percent of said herbal formulation.

10. The capsule, pill, or gummy treat herbal formulation claim 1, wherein the concentration of oregano extract ranges from 5.2 weight percent to 6.4 weight percent of said herbal formulation.

11. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of garlic extract ranges from 10.4 weight percent to 12.7 weight percent of said herbal formulation.

12. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of tumeric extract ranges from 3.4 weight percent to 4.2 weight percent of said herbal formulation.

13. The capsule, pill, or gummy treat herbal formulation of claim 1, wherein the concentration of vitamin E ranges from 20.8 weight percent to 25.5 weight percent of said herbal formulation.

14. The capsule, pill, or gummy treat herbal formulation of claim 1 in an oral dosage form that contains from about 650 mg to about 1950 mg of said herbal formulation.

15. The capsule, pill, or gummy treat herbal formulation of claim 1 consisting essentially of from about 325 mg to about 975 mg of said herbal formulation.

16. A capsule, pill, or gummy treat herbal formulation consisting essentially of: cat's claw extract in an amount ranging from 4.7-7.0 percent by weight; Astragalus extract in an amount ranging from 4.7-7.0 percent by weight; Echinacea extract in an amount ranging from 4.6-6.9 percent by weight; Moringa extract in an amount ranging from 14.8-22.2 percent by weight; astaxanthin in an amount ranging from 0.31-0.46 percent by weight; black elderberry extract in an amount ranging from 4.3-6.5 percent by weight; vitamin B12 in an amount ranging from 8.0-12.0 percent by weight; blackseed extract in an amount ranging from 3.1-4.6 percent by weight; oregano extract in an amount ranging from 4.6-6.9 percent by weight; garlic extract in an amount ranging from 9.3-13.9 percent by weight; tumeric extract in an amount ranging from 3.9-4.5 percent by weight; and vitamin E in an amount ranging from 18.5-27.8 percent by weight.

Description

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

(1) There will now be shown and described, by way of non-limiting examples, various instrumentalities for overcoming the problems discussed above. The instrumentalities disclosed herein overcome the problems outlined above and advance the art by providing an herbal formulation that, with proper dosages, offers a surprisingly high level of immune system support. The herbal formulations combine a plurality of agents that are known to boost the immune system. Powerful antioxidants are also combined to provide additional immune support that is particularly effective when the body of an infected individual is fighting an active infection. Overall, the combined ingredients have a broad-spectrum effect against many types of bacterial and viral infections. Results that have been achieved against viral infections are surprisingly good.

(2) Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by persons having ordinary skill in the art to which the invention pertains. Although any methods and materials similar or equivalent to those described herein can be used in the practice for testing of the present invention, the preferred materials and methods are described herein. In describing and claiming the present invention, the following terminology will be used. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.

(3) The articles “a” and “an” are used herein to refer to one or to more than one (i.e., to at least one) of the grammatical object of the article. By way of example, “an element” means one element or more than one element.

(4) “About” as used herein when referring to a measurable value such as an amount, a temporal duration, and the like, is meant to encompass variations of ±20% or ±10%, more preferably ±5%, even more preferably ±1%, and still more preferably ±0.1% from the specified value, as such variations are appropriate to perform the disclosed methods.

(5) “Effective amount” or “therapeutically effective amount” are used interchangeably herein, and refer to an amount of a compound, formulation, material, or composition, as described herein effective to achieve a particular biological result or provides a therapeutic or prophylactic benefit. Such results may include, but are not limited to, a relief from symptoms, as determined by any means suitable in the art.

(6) Ranges: Throughout this disclosure, various aspects of the invention may be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible sub-ranges as well as individual numerical values within that range. For example, description of a range such as from 1-10 should be considered to have specifically disclosed sub-ranges such as from 1-3, from 1-4, from 1-5, from 2-4, from 2-5, from 2-8, from 3-9, etc., as well as individual numbers within that range, for example, 1, 2, 2.4, 2.7, 3, 3.6, 4, 5, 5.8, and 10. This applies regardless of the breadth of the range.

(7) The herbal formulations include a plurality of herbal materials, including plant material and extracts, that provide nutritional support for broad-spectrum immune system enhancement, together with a broad range of antioxidants. The table below provides a listing of these ingredients according to a range of concentrations and relative weights that are suitable for use in a dosage formulation.

(8) TABLE-US-00001 TABLE HERBAL FORMULATION CONTENT Most Exemplary Suitable Preferred Preferred Single Dose* Material (wt. %) (wt. %) (wt. %) Content (mg) Cat's Claw 4.7-7.0 5.3-6.5 5.6-6.2 76 Extract 20:1 (uncaria tomentosa) Astragalus 4.7-7.0 5.3-6.5 5.6-6.2 76 Extract 20:1 (astragalus propinquss) Echinacea 4.6-6 . 9 5.1-6.3 5.4-6.0 74 Extract 4:1 (echinacea angustafolia) Moringa Extract 14.8-22.2 16.7-20.4 17.6-19.5 240 20:1 (moringa oleifera) Astaxanthin 0.31-0.46 0.35-0.42 0.37-0.41 5 (haematococcus pluvialis) Black 4.3-6.5 4.9-5.9 5.1-5.7 70 Elderberry Extract (sambucus nigra) Vitamin B12  8.0-12.0 9.0-11.0  9.5-10.5 130 Blackseed 3.1-4.6 3.5-4.2 3.7-4.1 50 Extract (nigella sativa) Oregano Extract 4.6-6.9 5.2-6.4 5.5-6.1 75 (origanum vulgare) Garlic Extract  9.3-13.9 10.4-12.7 11.0-12.2 150 Tumeric Extract 3.9-4.5 3.4-4.2 3.6-4.0 49 Vitamin E 18.5-27.8 20.8-25.5 22.0-24.3 300 Total 1295 *To assist the body in fighting active infection

(9) In some embodiments, vitamin E may be provided as D-alpha-tocopheryl succinate, a natural and highly effective form of vitamin E.

(10) The foregoing ingredients may be combined into a dosage form using standard procedures known to the art for making a pill, capsule, or edible material, such as a gummy treat. The herbal formulation may also contain conventional food supplement fillers and extenders, if desired. The herbal formulation may be taken orally. A suitable dosage range is, for example, from about 3.6 mg/kg of body weight to about 10.6 mg/kg of body weight, taken three times a day after an individual is either exposed to an infectious agent or is initially becoming symptomatic to an infection. This amounts to a dosage of from about 650 mg to about 1950 mg for a person of average weight. A more preferred dosage range for this use is from about 5.1 mg/kg of body weight to about 9.4 mg/kg of body weight, taken three times a day, which is from about 910 mg to about 1590 mg for a person of average weight. The most preferred dosage range for this use is about 7.2 mg/kg of body weight taken three times a day or about 1300 mg for a person of average weight. Optionally, an initial double dosage (i.e., two of any of these dosages) may be administered to an individual after the individual has either been exposed to an infectious agent or has become symptomatic.

(11) These dosages may be halved and taken once a day for maintenance or prophylactic support of healthy immune function. For example, a maintenance dosage suitably includes a dosage of about 1.8 mg/kg of body weight to about 5.3 mg/kg of body weight taken once a day, which amounts to from about 325 mg to about 975 mg for a person of average weight. A more preferred maintenance dose is from about 2.5 mg/kg of body weight to about 4.7 mg/kg of body weight taken once a day, which is from about 455 mg to about 855 mg for a person of average weight. The most preferred maintenance dosage range for this use is about 3.6 mg/kg of body weight taken once a day, or about 650 mg for a person of average weight.

(12) It will be appreciated from a review of these numbers that any type of dosage form may contain half of the desired dosage for fighting an active infection because this amount taken once a day for maintenance is half of the dosage taken three times a day when the body is fighting an active infection or has been exposed to an infection. A individual may, accordingly, take a single dose form for maintenance over a period of at least several days and two dosages at other times in the case of active infection.

WORKING EXAMPLES

(13) Influenza: A plurality of individuals are administered the exemplary formulation shown in the Table above over an extended period of time. The formulation is administered to each individual immediately upon the individual becoming symptomatic for infection by the influenza virus, these symptoms including fever, body aches, chills, muscle weakness. In substantially all cases, the individual becomes asymptomatic, and on average this occurs within 6 to 8 hours of the administration. The asymptomatic individuals do, however, for a time continue to cough up extra phlegm and mucus.

(14) COVID: Two work colleagues made a business trip together and worked in an office environment in close proximity to one another over a period of days. Both colleagues became ill and were confirmed by testing to have COVID. One colleague took the exemplary formulation as described in the Table above and became asymptomatic within 48 hours. The other colleague did not take the formulation, was hospitalized and almost died. In my most recent discovery, one person tested positive for COVID and had just about all of the symptoms except for issues with their taste buds. The asymptomatic individual did, however, for a time continue to cough up extra phlegm and mucus.

(15) Prophylactic Use: When taken every day, the above formulation helps prevent an individual from catching the common cold, the flu, and even helps prevent an individual from catching COVID.

(16) Having herein set forth preferred embodiments of the present invention, it is anticipated that suitable modifications can be made thereto which will nonetheless remain within the scope of the invention. The invention shall therefore only be construed in accordance with the following claims: